IOVA Stock-Based Compensation
Iovance Biotherapeutics Inc · Stock-Based Compensation
IOVA Stock-Based Compensation
Latest reported$46.72Mperiod ending
IOVA TTM Stock-Based Comp ($0.00 → $46.72M)
TTM stock-based compensation
High-resolution chart · PNG
IOVA stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 46,719,000 | |
| 49,929,000 | |
| 61,575,000 | |
| 80,735,000 | |
| 99,841,000 | |
| 115,364,000 | |
| 109,627,000 | |
| 93,049,000 | |
| 77,864,000 | |
| 64,138,000 | |
| 62,625,000 | |
| 67,735,000 | |
| 71,694,000 | |
| 77,422,000 | |
| 84,022,000 | |
| 83,617,000 | |
| 83,143,000 | |
| 75,089,000 | |
| 69,765,000 | |
| 50,661,000 | |
| 42,061,000 | |
| 38,184,000 | |
| 21,243,000 | |
| 21,243,000 | |
| 17,135,000 | |
| 13,024,000 | |
| 18,870,000 | |
| 24,055,000 | |
| 22,973,000 | |
| 21,769,000 | |
| 20,027,000 | |
| 17,602,000 | |
| 14,705,000 | |
| 12,776,000 | |
| 11,968,000 | |
| 12,331,000 | |
| 18,357,000 | |
| 16,987,000 | |
| 15,470,000 | |
| 15,019,000 | |
| 8,761,000 | |
| 8,761,000 | |
| 8,449,000 | |
| 6,869,000 | |
| 5,422,000 | |
| 4,378,678 | |
| 3,078,735 | |
| 19,306,863 | |
| 20,825,926 | |
| 20,079,248 | |
| 19,999,577 | |
| 3,600,333 | |
| 1,838,941 | |
| 1,705,941 | |
| 1,618,555 | |
| 697,671 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |